SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950133-02-001363
Filing Date
2002-04-04
Accepted
2002-04-04 00:00:00
Documents
7
Period of Report
2002-05-14

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT w58609def14a.htm DEF 14A 461269
3 GRAPHIC w58609guiphal1.gif GRAPHIC 7518
4 GRAPHIC w58609crsmith1.gif GRAPHIC 5236
5 GRAPHIC w58609nanlins1.gif GRAPHIC 4868
6 GRAPHIC w58609w5860901.gif GRAPHIC 11656
7 GRAPHIC w58609proxycardxbox.gif GRAPHIC 1319
8 GRAPHIC w58609proxycardbox.gif GRAPHIC 1214
  Complete submission text file 0000950133-02-001363.txt   495133
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Filer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-23736 | Film No.: 02601562
SIC: 2834 Pharmaceutical Preparations